Antibody Spike Months After Ebola Infection Surprisingly Common
Antibody Spike Months After Ebola Infection Surprisingly Common
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
Antibody Spike Months After Ebola Infection Surprisingly Common
Antibody Spike Months After Ebola Infection Surprisingly Common

A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.

A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.

convalescent plasma
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Alakananda Dasgupta | Sep 15, 2020
A randomized controlled trial on the use of convalescent plasma therapy to treat coronavirus infections—the first in the world to be completed—yields disappointing results, but some doctors are not discouraged.
Doctors Forge Ahead with Plasma for COVID-19, Benefits Uncertain
Doctors Forge Ahead with Plasma for COVID-19, Benefits Uncertain
Shawna Williams | Aug 14, 2020
Researchers say the popularity of convalescent plasma makes it more difficult to gather high-quality data on its efficacy.
FDA to Allow for Plasma Therapy for COVID-19 Patients
FDA to Allow for Plasma Therapy for COVID-19 Patients
Lisa Winter | Mar 26, 2020
Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.